AZ sells rights to statin med Crestor to Grünenthal
Grünenthal will pay $320m upfront for the rights
1st December 2020
-
Star tracking across the pharmaverse
While the COVID-19 menace has wreaked havoc across global industries, pharma’s commitment to logistical zeal has provided a supersonic slipstream to optimal performance, not to mention salvation for millions of patients
-
Data – the key to reshaping patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
-
Artificial inventors
The question of artificial intelligence as an inventor – and what it means for drug discovery
News
View all
Patient Partnership Index 2020 Insights Report published
Follows on from success of the inaugural Patient Partnership Index Conference
1st December 2020
COVID-19 could cause long-term lung damage, research finds
Research conducted at Oxford University used new scanning method
1st December 2020
Eisai enters collaboration agreement with Wren Therapeutics
Companies will aim to advance drug discovery for synucleinopathies
1st December 2020
Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial
Commonly used anti-inflammatory drug added to list of potential treatments
30th November 2020
Top trending
-
NHS to trial innovative cancer blood test
-
Pfizer to build R&D facility in Wuhan, China
-
NICE backs use of new treatment for multiple myeloma
-
NICE turns down Novartis' Adakveo
-
GSK launches late-stage study of RSV vaccine in pregnant mothers
-
Moderna signs deal with EU for 160 million COVID-19 vaccine doses
Web Exclusives
View all
The COVID vaccines safety net
The need to implement rigorous post-authorisation monitoring programmes as an added safety net for COVID-19 vaccines
Working together
Why combining expertise from the NHS and pharmaceutical experts will deliver better patient outcomes
Now or never
The security of our medicines supply chain matters
A prime target
How can pharma protect itself from cyber criminals?
Magazine
View more from the latest edition
Patient Files: Spinal muscular atrophy (SMA)
Cheryl Yoder shares her family’s experiences with this rare, genetic disorder
Branching out
Pharma companies have improved how they engage with healthcare providers during COVID-19, says Accenture’s Brad Michel
Decentralising research
Revolutionising clinical trials with wearables and digital endpoints
Reinventing patient engagement
Lessons from the Patient Partnership Index conference
Artificial inventors
The question of artificial intelligence as an inventor – and what it means for drug discovery
Keeping trial data alive
Insight into the conduct of clinical trials and managing data amid the pandemic
Maintaining cross-border medicines supply
Updated guidelines from the European Medicines Agency for pharmaceuticals marketing authorisation holders offer new clarity on what they must do to maintain continuity of supply of UK-registered products in Europe once the Brexit transition period ends.
Rethinking cancer detection
If we are to truly beat cancer, we need to pay as much attention to detecting it as we do treating it
Thought Leadership
View all
Let’s Have A Chat: Why Bristol Myers Squibb is tackling loneliness
Keeping the spirit of connection alive through the Have a Chat campaign
The concordance conundrum – the tech divide
Consultations in a virtual world
The concordance conundrum: the value of improving patient experience
The art of active listening
New product vs established brand investment?
A trade-off you no longer have to make in this changing world
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
